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Human Bocavirus
in Hospitalized
Children, South
Africa
To the Editor: In recent years,
several novel respiratory viruses have
been identified. These include human
metapneumovirus (HMPV) (1),
severe acute respiratory syndrome–
associated coronavirus (2), human
coronavirus (HCoV) NL63 (3,4),
HCoV HKU1 (5), and, most recently,
human bocavirus (HBoV) (6). The
latter belongs to the Parvoviridae
family and is most closely related to
bovine parvovirus and canine minute
virus (CnMV), which are members of
the genus Bocavirus (6). Parvovirus
B19 and HBoV are the only 2 par-
voviruses known to be pathogenic to
humans, but the relevance of HBoV
infection in the clinical setting is not
known.
In this retrospective study, 341
nasopharyngeal and bronchoalveolar
lavage samples were taken from chil-
dren (age 2 days–12 years) hospital-
ized with respiratory tract infections
in 2004 in the Red Cross War
Memorial Children’s Hospital, Cape
Town, South Africa. Samples were
originally screened by using an indi-
rect immunofluorescence assay (Light
Diagnostics, Chemicon International,
Temecula, CA, USA) for common
respiratory viruses, including respira-
tory syncytial virus; influenza virus A
and B; parainfluenza viruses 1, 2, and
3; adenovirus; and cytomegalovirus.
Subsequently, HMPV and HCoV
NL63 were detected by using reverse
transcription–PCR (1,3). 
Samples were also screened for
HBoV DNA. DNA was extracted by
using the QIAamp DNA blood mini
kit according to the manufacturer’s
instructions (Qiagen Inc., Valencia,
CA, USA). PCR amplification of a
region of the NP-1 gene and the 3′
portion of the VP1/2 capsid gene of
HBoV was performed. Briefly, 10 µL
DNA was added to a 50-µL PCR mix
containing 2 IU Supertherm poly-
merase (JMR Holdings, Kent, UK),
1.5 mmol/L MgCl2, 200 µmol/L each
dNTP, and 0.2 µmol/L primers NP-1
s1 (5′-TAACTGCTCCAGCAAGTC-
CTCCA) and NP-1 as1 (5′-GGA-
AGCTCTGTGTTGACTGAAT). To
improve sensitivity, a second semi-
nested reaction with 2.5 µL outer
product and NP-1 as1 primer and NP-
1 s2 (5′-CTCACCTGCGAGCTCTG-
TAAGTA) primer was performed at
an annealing temperature of 55°C.
Negative controls were used, and
appropriate measures were taken to
prevent contamination (7). Samples
with an NP-1–specific PCR product
of 368 bp were confirmed by amplify-
ing a 980-bp product of the VP1/2
capsid gene in a similar seminested
PCR amplification protocol (primers
VP s1 5′-GCACTTCTGTATCAGAT-
GCCTT, VP as1 5′-CGTGGTATG-
TAGGCGTGTAG, and VP s2 5′-
CTTAGAACTGGTGAGAG-
CACTG). A selection of the inner
VP1/2 amplicons obtained from sam-
ples taken over the year were
sequenced directly and aligned in
ClustalX, and a phylogenetic tree was
constructed with the Kimura 2-param-
eter neighbor-joining method with
1,000 bootstrap resamplings. Com-
parative sequences were obtained
from GenBank and included HBoV
isolate st1 (DQ000495), HBoV isolate
st2 (DQ000496), and a CnMV isolate
(NC_004442). Nucleotide sequences
from this study were deposited into
GenBank (DQ317539–DQ317561).
HBoV DNA was detected in 38
(11%) samples from 35 children, all
<2 years of age. Infections occurred
throughout the year, although more
positive results were found in the
autumn/winter season from April to
August (63%) than during the rest of
the year (37%). A diagnosis of pneu-
monia or lower respiratory tract infec-
tion was made for 30 (86%) children.
Thirteen (37%) HBoV-positive chil-
dren required admission to the inten-
sive care unit. Comorbid conditions
were present in 22 children: cystic
fibrosis (1), spinal muscular atrophy
type 1 (4), Down syndrome (4), car-
diac abnormalities (5), and HIV infec-
tion (8). Co-infection with a range of
viral and bacterial organisms was a
common feature in HBoV-positive
children and was found in 14 (37%)
samples. These organisms included
cytomegalovirus (4), respiratory syn-
cytial virus (2), adenovirus (1), HCoV
NL63 (1), parainfluenza 3 (1),
Staphylococcus aureus (1),  Strepto-
coccus pneumoniae (1),  Klebsiella
pneumoniae (1), and Pneumocystis
jirovecii (2). However, in the remain-
ing 24 (63%) samples, no other infec-
tious agent was identified.
HBoV was detected in serial sam-
ples from 2 children during a 2-day
(V04/2591 and V04/2613) and 7-day
(V04/2599 and V04/2631) period. In
both, sequences were identical and
clustered within the proposed sub-
group B. In a third child, HBoV
sequences were detected in 2 samples
taken 2 months apart; in these sam-
ples, the isolates were different
(V04/1159 and V04/2062) (Figure).
Phylogenetic analysis of the 3′
region of the VP1/2 capsid gene
(Figure) showed that the Cape Town
strains of HBoV were most closely
aligned with the HBoV st2 prototype
strain. The nucleotide sequence
homology was 98% with 1 amino acid
change, N474S. The HBoVst2 branch
could be separated into 2 lineages, A
and B, with a 3-nucleotide change at
positions 4615 (A/G), 4756 (A/C),
and 4888 (G/A) on the basis of the
numbering of the HBoV st2 sequence.
These results suggest that HBoV
infection occurs predominantly during
the winter season and that children <2
years of age are most at risk. The study
by Sloots et al. (8) also found HBoV
infections mainly during the winter
months (61%) in children <2 years.
Although co-infections were found,
the proportion (63%) of children in
whom only HBoV was detected was
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substantial. These findings suggest
that HBoV may play a role in respira-
tory tract infections in young children
who require hospitalization.
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Shigella sonnei
Outbreak among
Homosexual Men,
London 
To the Editor: In the summer of
2004, genitourinary medicine clinics
in London reported cases of Shigella
sonnei with a novel phage type pattern
(later designated PTQ). Outbreak case
finding involved local laboratories
and genitourinary medicine physi-
cians in London, as well as the nation-
al reference laboratory. A case was
considered confirmed if S. sonnei
PTQ was isolated from January 2004
through April 2005, and the patient
had not traveled outside the country
the week before illness. Possible cases
were defined as for confirmed cases
but were so designated when patient
had a history of foreign travel in the
week before illness or when travel
history was unknown. From October
2004, when we became aware of the
outbreak, until December 2004, we
conducted telephone interviews with
newly identified case-patients. For
cases that occurred before October
2004, and from January 2005 through
April 2005, information was obtained
from laboratory records only.
Strains were phage typed by using
the scheme described by Hammer-
strom, Kallings, and Sjoberg, accord-
ing to a protocol supplied by R.
Wollin (1,2). The scheme consists of
11 phages and is based on the typing
of the rough phase II variant of S. son-
nei. The scheme comprises defined
phage types (PT) 1–100 and provi-
sional PTs A–P. Cultures were grown
overnight on MacConkey agar, and a
rough colony was placed in  nutrient
broth and grown for 18 hours at 37°C.
The broth culture was then used to
flood a nutrient agar plate and, once
dry, spotted with the 11 phages and
incubated at 37°C for 5 hours. The
patterns of lysis were recorded and
compared with those indicated on the
typing chart. All isolates were
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Figure. Phylogenetic analysis of a
980-bp region of the human
bocavirus (HBoV) VP1/2 capsid
gene from South African children
with respiratory tract disease. The
tree was constructed by using the
neighbor-joining method with
1,000 bootstrap resamplings. All
nucleotide sequences were sub-
mitted to GenBank (accession nos.
DQ317539–DQ317561). CnMV,
canine minute virus.